Nonstatin Lipid-Lowering Therapy in Medicare: Use of Ezetimibe, Fibrates, Niacin, and Bile Acid Sequestrants Among Medicare Beneficiaries With CHD in 2007 Through 2011 by Calendar Quarter
(A) Shows data for Medicare beneficiaries on statins. (B) Shows data for Medicare beneficiaries not on statins. Arrows indicate time points when key study results were released. ENHANCE = Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression; ACCORD = Action to Control Cardiovascular Risk in Diabetes; AIM HIGH = Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes.